ミズホメディーの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/07 | 1,372 | 1,409 | 1,341 | 1,373 | -89 | -6.1% | 203,800 |
| 2025/04/04 | 1,467 | 1,480 | 1,441 | 1,462 | -25 | -1.7% | 164,700 |
| 2025/04/03 | 1,482 | 1,498 | 1,475 | 1,487 | -18 | -1.2% | 107,000 |
| 2025/04/02 | 1,517 | 1,517 | 1,505 | 1,505 | -6 | -0.4% | 55,200 |
| 2025/04/01 | 1,524 | 1,528 | 1,511 | 1,511 | -1 | -0.1% | 47,000 |
| 2025/03/31 | 1,510 | 1,521 | 1,504 | 1,512 | -22 | -1.4% | 96,300 |
| 2025/03/28 | 1,540 | 1,550 | 1,525 | 1,534 | +5 | +0.3% | 186,800 |
| 2025/03/27 | 1,522 | 1,529 | 1,510 | 1,529 | +7 | +0.5% | 93,000 |
| 2025/03/26 | 1,507 | 1,528 | 1,503 | 1,522 | +7 | +0.5% | 69,700 |
| 2025/03/25 | 1,513 | 1,523 | 1,501 | 1,515 | +11 | +0.7% | 116,000 |
| 2025/03/24 | 1,490 | 1,510 | 1,486 | 1,504 | +16 | +1.1% | 86,500 |
| 2025/03/21 | 1,474 | 1,495 | 1,473 | 1,488 | +25 | +1.7% | 98,100 |
| 2025/03/19 | 1,459 | 1,473 | 1,459 | 1,463 | +4 | +0.3% | 57,900 |
| 2025/03/18 | 1,460 | 1,472 | 1,457 | 1,459 | +9 | +0.6% | 76,000 |
| 2025/03/17 | 1,449 | 1,461 | 1,446 | 1,450 | +4 | +0.3% | 57,800 |
| 2025/03/14 | 1,444 | 1,450 | 1,438 | 1,446 | -1 | -0.1% | 46,000 |
| 2025/03/13 | 1,452 | 1,462 | 1,446 | 1,447 | -2 | -0.1% | 60,300 |
| 2025/03/12 | 1,453 | 1,460 | 1,445 | 1,449 | +4 | +0.3% | 51,900 |
| 2025/03/11 | 1,445 | 1,451 | 1,435 | 1,445 | -12 | -0.8% | 94,400 |
| 2025/03/10 | 1,455 | 1,459 | 1,450 | 1,457 | +5 | +0.3% | 52,500 |
| 2025/03/07 | 1,448 | 1,459 | 1,443 | 1,452 | +4 | +0.3% | 49,700 |
| 2025/03/06 | 1,446 | 1,458 | 1,446 | 1,448 | ±0 | ±0% | 57,200 |
| 2025/03/05 | 1,444 | 1,451 | 1,439 | 1,448 | -1 | -0.1% | 35,100 |
| 2025/03/04 | 1,449 | 1,449 | 1,433 | 1,449 | +6 | +0.4% | 45,000 |
| 2025/03/03 | 1,441 | 1,450 | 1,439 | 1,443 | +3 | +0.2% | 35,300 |
| 2025/02/28 | 1,441 | 1,452 | 1,432 | 1,440 | -5 | -0.3% | 104,100 |
| 2025/02/27 | 1,451 | 1,452 | 1,441 | 1,445 | -6 | -0.4% | 63,900 |
| 2025/02/26 | 1,472 | 1,477 | 1,443 | 1,451 | -21 | -1.4% | 69,300 |
| 2025/02/25 | 1,448 | 1,485 | 1,448 | 1,472 | +25 | +1.7% | 99,100 |
| 2025/02/21 | 1,456 | 1,459 | 1,445 | 1,447 | -15 | -1% | 75,200 |
| 2025/02/20 | 1,474 | 1,474 | 1,457 | 1,462 | -9 | -0.6% | 57,800 |
| 2025/02/19 | 1,475 | 1,480 | 1,471 | 1,471 | -6 | -0.4% | 54,100 |
| 2025/02/18 | 1,478 | 1,478 | 1,472 | 1,477 | +6 | +0.4% | 29,900 |
| 2025/02/17 | 1,482 | 1,487 | 1,471 | 1,471 | -11 | -0.7% | 50,400 |
| 2025/02/14 | 1,492 | 1,494 | 1,482 | 1,482 | -18 | -1.2% | 54,700 |
| 2025/02/13 | 1,496 | 1,503 | 1,491 | 1,500 | -3 | -0.2% | 58,600 |
| 2025/02/12 | 1,492 | 1,518 | 1,492 | 1,503 | -10 | -0.7% | 117,900 |
| 2025/02/10 | 1,471 | 1,522 | 1,471 | 1,513 | +64 | +4.4% | 247,000 |
| 2025/02/07 | 1,500 | 1,507 | 1,445 | 1,449 | -53 | -3.5% | 318,000 |
| 2025/02/06 | 1,489 | 1,505 | 1,489 | 1,502 | +10 | +0.7% | 85,300 |
| 2025/02/05 | 1,494 | 1,495 | 1,482 | 1,492 | +1 | +0.1% | 80,900 |
| 2025/02/04 | 1,507 | 1,511 | 1,491 | 1,491 | -16 | -1.1% | 108,200 |
| 2025/02/03 | 1,515 | 1,515 | 1,499 | 1,507 | -8 | -0.5% | 123,600 |
| 2025/01/31 | 1,528 | 1,528 | 1,511 | 1,515 | -13 | -0.9% | 80,300 |
| 2025/01/30 | 1,521 | 1,528 | 1,512 | 1,528 | +13 | +0.9% | 103,900 |
| 2025/01/29 | 1,524 | 1,541 | 1,512 | 1,515 | -10 | -0.7% | 215,500 |
| 2025/01/28 | 1,500 | 1,533 | 1,488 | 1,525 | +1 | +0.1% | 378,500 |
| 2025/01/27 | 1,448 | 1,549 | 1,433 | 1,524 | +93 | +6.5% | 734,300 |
| 2025/01/24 | 1,418 | 1,435 | 1,418 | 1,431 | +17 | +1.2% | 91,100 |
| 2025/01/23 | 1,434 | 1,435 | 1,413 | 1,414 | -20 | -1.4% | 192,400 |
1～
50
件表示中 / 2271件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ミズホメディ | 137,300円 | +1.2% | -13.9% | 6.19% | 8.09倍 | 1.51倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ダイト | 205,600円 | +4.5% | -10.8% | 3.40% | 13.51倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| 富士製薬 | 118,100円 | +15.7% | +5.3% | 3.85% | 8.54倍 | 0.63倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| ヘリオス | 19,600円 | +150.0% | - | 0.00% | - | 9.62倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| 扶桑薬 | 203,900円 | +8.3% | +98.1% | 4.02% | 6.70倍 | 0.46倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム
